Incidental Splenic Lesions

Reference Images

Color incidental splenic mass management flowchart
Mass Management ColorClick to enlarge
Incidental splenic mass quick reference table
Quick ReferenceClick to enlarge
Incidental splenic lesions on CT flowchart
CT AlgorithmClick to enlarge
Splenic lesion imaging pattern differential
Pattern DDxClick to enlarge
Incidental splenic mass management flowchart
Mass ManagementClick to enlarge

Initial Triage

First question Benign appearance, prior stability, cancer history, and symptoms drive management more than size alone.

Benign appearance

  • Simple cyst, accessory spleen, healed granulomatous calcification, or classic benign vascular lesion: usually no follow-up.
  • Benign CT features include smooth margins, homogeneous low attenuation, no enhancement, and no aggressive behavior.
  • If a lesion is unchanged for at least 1 year and there is no cancer history, it is generally treated as benign.

Nondiagnostic appearance

  • Look for prior imaging first.
  • If stable for at least 1 year: no further evaluation.
  • If new, enlarging, or no prior comparison: choose follow-up MRI, PET, or biopsy based on cancer history and suspicious features.

Imaging Patterns

Cystic / benign

  • Simple epithelial cyst: thin wall, fluid attenuation/signal, no enhancement.
  • Pseudocyst: may have thick wall, calcification, or posttraumatic history.
  • Accessory spleen: same enhancement and signal as spleen on every phase/sequence.

Solid vascular / multiple

  • Hemangioma: progressive or persistent enhancement.
  • Hamartoma: early arterial enhancement with delayed equilibration.
  • SANT: fibrous rim/radiating bands or spoke-wheel enhancement pattern.
  • Multiple lesions raise inflammatory, lymphoma, littoral cell angioma, or metastasis considerations.

Indeterminate / Suspicious

Escalate

  • Suspicious features: heterogeneous enhancement, irregular margins, necrosis, vascular invasion, or rapid growth.
  • Known cancer history: lower threshold for MRI, PET, or biopsy, especially for lesions 1 cm or larger.
  • No cancer history with indeterminate features: MRI follow-up at about 6 and 12 months is a common pathway.

Symptoms

  • Pain attributable to the spleen: consider surgical consultation; MRI if further characterization is needed.
  • Systemic symptoms or splenomegaly: consider lymphoma, infection, sarcoid, inflammatory disease, metastasis, or angiosarcoma.
  • Biopsy is reserved for cases where imaging remains indeterminate and tissue diagnosis will change management.

Sources

Secondary Links